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  International Space Station (ISS) assembly complete ushered a new era focused on utilization 
of this state-of-the-art orbiting laboratory to advance science and technology research in a wide 
array of disciplines, with benefits to Earth and space exploration.  ISS enabling capability for 
research in cellular and molecular biology includes equipment for in situ, on-orbit analysis of 
biomolecules.  Applications of this growing capability range from biomedicine and 
biotechnology to the emerging field of Omics.  For example, Biomolecule Sequencer is a space-
based miniature DNA sequencer that provides nucleotide sequence data for entire samples, 
which may be used for purposes such as microorganism identification and astrobiology.  It 
complements the use of WetLab-2 SmartCycler™, which extracts RNA and provides real-time 
quantitative gene expression data analysis from biospecimens sampled or cultured onboard the 
ISS, for downlink to ground investigators, with applications ranging from clinical tissue 
evaluation to multigenerational assessment of organismal alterations.  And the Genes in Space-1 
investigation, aimed at examining epigenetic changes, employs polymerase chain reaction to 
detect immune system alterations.  In addition, an increasing assortment of tools to visualize the 
subcellular distribution of tagged macromolecules is becoming available onboard the ISS.  For 
instance, the NASA LMM (Light Microscopy Module) is a flexible light microscopy imaging 
facility that enables imaging of physical and biological microscopic phenomena in microgravity.  
Another light microscopy system modified for use in space to image life sciences payloads is 
initially used by the Heart Cells investigation (“Effects of Microgravity on Stem Cell-Derived 
Cardiomyocytes for Human Cardiovascular Disease Modeling and Drug Discovery”).  Also, the 
JAXA Microscope system can perform remotely controllable light, phase-contrast, and 
fluorescent observations.  And upcoming confocal microscopy capability will allow for optical 
sectioning of biological tissues to determine microanatomical localization of biomarkers.  
Furthermore, NASA’s geneLAB effort addresses integration of genomic, epigenomic, 
transcriptomic, proteomic and metabolomic datasets, by applying an innovative open source 
science platform for multi-investigator high throughput utilization of the ISS.  In sum, the 
expanding ISS capability for analysis of biomolecules is enabling innovative research in a broad 
spectrum of areas such as cellular and molecular biology, biotechnology, tissue engineering, 
biomedicine, and Omics, providing manifold benefits for humanity. 
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